Planetary Drug Ledger
AllDrugs.World
Global drug consumption & production, on one mapBeta — synthetic dashboard, data-ready layout.

A single pane of glass for all drug flows worldwide.

AllDrugs.World maps global drug consumption and production — by country, by molecule, by USD value. Track regulated medicines, over-the-counter products, and high-level illicit market estimates from public-health and enforcement sources.

Designed for regulators, public-health teams, researchers, banks, and investigative journalists who need a neutral, data-driven view of global drug flows.

Live data: Figures sourced from RAND, UNODC, EMCDDA, WHO, and national health agencies. Updated daily via automated pipeline.

Annual global spend (est.)
$1.61T
regulated + estimated illicit
Countries tracked
6
UN-recognized & territories
Active substances
3,200+
by ATC / UNODC class
Last data refresh
Jan 13, 2025
from upstream data sources

Drug classes & flows on AllDrugs.World

Group substances by regulatory class, molecule, or commercial family. Each node can be tied to origin country, manufacturing hubs, distribution corridors, and end-market consumption in both volume and USD terms.

Regulated prescription (ATC)OTC & non-prescriptionGenerics & biosimilarsVaccines & biologicsControlled substancesIllicit market estimates
Top molecule by spend
Sample: Atorvastatin

Concentration of spend in chronic therapies vs. acute / short-course treatments.

Origin vs. consumption
Export hubs > 70% of output

Map manufacturing clusters (e.g., EU, India, China, LATAM) against final patient markets.

Illicit estimates
UNODC / EMCDDA overlay

High-level volume & value ranges for non-regulated markets, for policy & risk analysis only.

Financial flows
USD, EUR, local FX

Optional linkage to trade finance, insurance, AML, and credit-risk datasets.

Methodology & safeguards

AllDrugs.World is an analytics-only platform. No marketing, no sourcing, no facilitation of illegal activity. Data is aggregated from regulators, health agencies, customs & trade statistics, multilateral reports, and vetted research partners.

Data ingestion
ETL + validation pipeline

Standardized intake from WHO, OECD, UNODC, national agencies, wholesalers, and open-source trade data.

Privacy & ethics
No patient-level data

All figures are macro-level and anonymized. The platform is designed for system-level insight, not personal profiling.

Compliance mode
Risk & AML lenses

Optional overlays for banks and regulators to detect anomalies between production, trade, and consumption.

Disclaimer. All content on AllDrugs.World is for informational, research, and risk-management purposes only. It does not encourage, facilitate, or condone illegal drug manufacturing, distribution, or consumption. Illicit market statistics, where included, are high-level estimates from public sources and may be incomplete or uncertain.